Humasis Co. Ltd.

Humasis Co. Ltd.

Share · KR7205470008 (XKOS)
Overview
AI-Powered Analysis
Fundamental Analysis
Find out what the numbers really say — before the market does
Analyze now
News Sentiment
Are today's headlines a buy signal or a red flag?
Analyze now
Buy / Hold / Sell
Should you Buy, Hold, or Sell? Get the AI verdict now.
Analyze now
Risk Assessment
Uncover hidden risks before they hit your portfolio.
Analyze now
Fair Value
Is this stock cheap, fairly priced, or overvalued?
Analyze now
Latest AI Analyses of Humasis Co. Ltd.
No Price
Closing Price XKOS 13.04.2026: 801,00 KRW
13.04.2026 09:00
Current Prices from Humasis Co. Ltd.
ExchangeTickerCurrencyLast TradePriceDaily Change
XKOS: KOSDAQ
KOSDAQ
205470.KQ
KRW
13.04.2026 09:00
801,00 KRW
-
Share Float & Liquidity
Free Float 85,36 %
Shares Float 19,32 M
Shares Outstanding 22,63 M
Company Profile for Humasis Co. Ltd. Share
Humasis Co. Ltd. develops, manufactures, and markets in-vitro diagnostics for the detection of cardiac marker, fertility hormone, infectious disease, tumor marker, and cotinine for home and laboratory use in South Korea and internationally. It offers pregnancy and ovulation self-test products; Hubi-Quan Pro, a self-contained and cartridge reader to provide rapid quantitative results for membrane-based lateral flow immunochromatographic assays; and various rapid test kits. The company was founded in 2000 and is based in Anyang, South Korea.

Company Data

Name Humasis Co. Ltd.
Company Humasis Co. Ltd.
Website http://www.humasis.com
Primary Exchange XKOS KOSDAQ
ISIN KR7205470008
Asset Class Share
Sector Healthcare
Industry Medical - Equipment & Services
CEO Sung-gon Kim
Market Capitalization 453 Mrd.
Country South Korea
Currency KRW
Employees 0,1 T
Address 504, Shinwon Vision Tower, 431-836 Anyang
IPO Date 2017-09-27
Dividends from 'Humasis Co. Ltd.'
Ex-Date Dividend per Share
28.12.2022 200,00 KRW
29.12.2021 200,00 KRW

Stock Splits

Date Split
24.03.2023 4:1

Ticker Symbols

Name Symbol
KOSDAQ 205470.KQ
More Shares
Investors who hold Humasis Co. Ltd. also have the following shares in their portfolio:
LCI IND 21/26 CV
LCI IND 21/26 CV Bond
Rapport Therapeutics, Inc. - Common Stock
Rapport Therapeutics, Inc. - Common Stock Share